Robert Jeraj

Credentials: PhD

Position title: Professor, Medical Physics and Human Oncology


Phone: 608/263-8619

7033 WIMR

Robert Jeraj is a primary advisor in the Department of Medical Physics.


B.Sc., Physics, University of Ljubljana, Slovenia

Ph.D., Physics, University of Ljubljana, Slovenia

Department Affilations

Medical Physics

Human Oncology

Research Interests

  • Tumor Heterogeneity and Treatment Resistance
  • Quantitative Imaging Biomarkers
  • Image Guidance for Precision Medicine
  • Modeling in Oncology and Neurology


Visit PubMed for an up-to-date list

  • Adhikarla, V and Jeraj, R, An imaging-based stochastic model for simulation of tumour vasculature, Phys Med Biol 57(19), 6103-6124 (2012).
  • Bowen, SR, Chappell, RJ, Bentzen, SM, Deveau, MA, Forrest, LJ, and Jeraj, R, Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: An exploratory study, Radiother Oncol (2012).
  • De Ruysscher, D, Nestle, U, Jeraj, R, and Macmanus, M, PET scans in radiotherapy planning of lung cancer, Lung Cancer 75(2), 141-5 (2012).
  • Gregoire, V, Jeraj, R, Lee, JA, and O’Sullivan, B, Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?, Lancet Oncol 13(7), e292-300 (2012).
  • Grudzinski, JJ, Floberg, JM, Mudd, SR, Jeffery, JJ, Peterson, ET, Nomura, A, Burnette, RR, Tome, WA, Weichert, JP, and Jeraj, R, Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT, Phys Med Biol 57(6), 1641-1657 (2012).
  • Kubicek, LN, Seo, S, Chappell, RJ, Jeraj, R, and Forrest, LJ, Helical tomotherapy setup variations in canine nasal tumor patients immobilized with a bite block, Vet Radiol Ultrasound 53(4), 474-81 (2012).
  • Titz, B, Kozak, KR, and Jeraj, R, Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data, Phys Med Biol 57(19), 6079-6101 (2012).
  • Vanderhoek, M, Perlman, SB, and Jeraj, R, Impact of the definition of peak standardized uptake value on quantification of treatment response, J Nucl Med 53(1), 4-11 (2012).
  • Balter, JM, Haffty, BG, Dunnick, NR, Siegel, EL, and Jeraj, R, (Imaging Opportunties Workshop Participants), Imaging opportunities in radiation oncology, Int J Radiat Oncol Biol Phys 79(2), 342-7 (2011).
  • Bortfeld, T and Jeraj, R, The physical basis and future of radiation therapy, Br J Radiol 84(1002), 485-98 (2011).
  • Bowen, SR, van der Kogel, AJ, Nordsmark, M, Bentzen, SM, and Jeraj, R, Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling, Nucl Med Biol 38(6), 771-80 (2011).
  • Liu, G, Jeraj, R, Vanderhoek, M, Perlman, S, Kolesar, J, Harrison, M, Simoncic, U, Eickhoff, J, Carmichael, L, Chao, B, Marnocha, R, Ivy, P, and Wilding, G, Pharmacodynamic Study Using FLT PET/CT in Patients with Renal Cell Cancer and Other Solid Malignancies Treated with Sunitinib Malate, Clin Cancer Res 17(24), 7634-44 (2011).
  • Simoncic, U and Jeraj, R, Cumulative input function method for linear compartmental models and spectral analysis in PET, J Cereb Blood Flow Metab 31(2), 750-6 (2011).
  • Vanderhoek, M, Juckett, MB, Perlman, SB, Nickles, RJ, and Jeraj, R, Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging, Leuk Res 35(3), 310-6 (2011).
  • Barbee, DL, Flynn, RT, Holden, JE, Nickles, RJ, and Jeraj, R, A method for partial volume correction of PET-imaged tumor heterogeneity using expectation maximization with a spatially varying point spread function, Phys Med Biol 55(1), 221-36 (2010).
  • Deveau, MA, Bowen, SR, Westerly, DC, and Jeraj, R, Feasibility and sensitivity study of helical tomotherapy for dose painting plans, Acta Oncol 49(7), 991-6 (2010).
  • Galavis, PE, Hollensen, C, Jallow, N, Paliwal, B, and Jeraj, R, Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters, Acta Oncol 49(7), 1012-6 (2010).
  • Grudzinski, JJ, Burnette, RR, Weichert, JP, and Jeraj, R, Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape, Cancer Biother Radiopharm 25(4), 417-26 (2010).
  • Grudzinski, JJ, Tome, W, Weichert, JP, and Jeraj, R, The biological effectiveness of targeted radionuclide therapy based on a whole-body pharmacokinetic model, Phys Med Biol 55(19), 5723-34 (2010).
  • Jeraj, R, Cao, Y, Ten Haken, RK, Hahn, C, and Marks, L, Imaging for assessment of radiation-induced normal tissue effects, Int J Radiat Oncol Biol Phys 76(3 Suppl), S140-4 (2010).
  • Korreman, SS, Ulrich, S, Bowen, S, Deveau, M, Bentzen, SM, and Jeraj, R, Feasibility of dose painting using volumetric modulated arc optimization and delivery, Acta Oncol 49(7), 964-71 (2010).
  • McCall, KC, Barbee, DL, Kissick, MW, and Jeraj, R, PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets, Phys Med Biol 55(10), 2789-806 (2010).


  • System and method for evaluation of disease burden, Wisconsin Alumni Research Foundation, U.S. Patent No. 9603567B2.
  • System and method for gradient assisted non-connected automatic Region (GANAR) analysis, Wisconsin Alumni Research Foundation, U.S. Patent No. 20150055849A1.
  • Treatment Planning System For Radiopharmaceuticals, Wisconsin Alumni Research Foundation, U.S. Patent No. 20110060602A1.
  • Method and apparatus for low dose computed tomography, Wisconsin Alumni Research Foundation, U.S. Patent No. EP1973469A2.
  • Small Field Intensity Modulated Radiation Therapy Machine, Wisconsin Alumni Research Foundation, U.S. Patent No. 20070242801A1.
  • Correction of patient rotation errors in radiotherapy using couch translation, Wisconsin Alumni Research Foundation, U.S. Patent No. 7302038B2.


  • American Association of Physicists in Medicine (AAPM, fellow)
  • American Physical Society (APS)
  • Institute of Physics (IoP; Fellow)
  • American Society of Clinical Oncology (ASCO)